Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Doses of Moderna's updated COVID-19 vaccine are expected to begin arriving in Canada 'within days,' a spokesperson for the ...

Doses of Novavax’s 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwide Novavax’s updated vaccine is the only protein-based option available in the U.S. this fall for ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.

Josh Lipton and Madison Mills monitor Novavax's upward stock reaction to this news. For more expert insight and the latest market action, click here to watch this full episode of Market ...

Shares of Novavax Inc. NVAX slid 2.86% to $12.56 Wednesday, on what proved to be an all-around dismal trading session for the ...

Health Canada has authorized Novavax's updated COVID-19 vaccine. THE CANADIAN PRESS/Andrew Vaughan-Pool Nuvaxovid is the second updated COVID-19 vaccine approved by Health Canada this week ...

Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

1:23 Most provinces have destroyed COVID-19 vaccines amid wait for new formula, here’s why Health Canada has authorized Novavax’s updated COVID-19 vaccine that protects against currently ...

Health Canada said Thursday it has authorized Novavax's updated COVID-19 vaccine for those aged 12 years and up. The product, called Nuvaxovid, is a protein-based vaccine. Health Canada said ...